Medline Inc.: Beware The Private Equity Overhang (NASDAQ:MDLN)
· seekingalpha.com
Medline Inc. faces pressure from private equity overhang and a recent downward revision in FY26 adj. EBITDA guidance. I rate the MDLN stock a hold. Read my full analysis.
Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a m...